Showing 1 - 10 of 4,368
Persistent link: https://www.econbiz.de/10011564535
Persistent link: https://www.econbiz.de/10002037672
Persistent link: https://www.econbiz.de/10011657068
Branded pharmaceutical manufacturers frequently offer "copay coupons'" that insulate consumers from cost-sharing, thereby undermining insurers' ability to influence drug utilization. We study the impact of copay coupons on branded drugs first facing generic entry between 2007 and 2010. To...
Persistent link: https://www.econbiz.de/10012455935
Branded pharmaceutical manufacturers frequently offer "copay coupons'" that insulate consumers from cost-sharing, thereby undermining insurers' ability to influence drug utilization. We study the impact of copay coupons on branded drugs first facing generic entry between 2007 and 2010. To...
Persistent link: https://www.econbiz.de/10012981093
cholesterol. The two brand-name products on the Norwegian markets were Provachol (atc code C10AA03) and Zocor (atc code C10AA01 … find that prices have a negative impact on transitions in the sense that an increase in the brand price will reduce the … transition from generics to brand and likewise an increase in the generic price will reduce the transition from brand to generics …
Persistent link: https://www.econbiz.de/10008697144
Persistent link: https://www.econbiz.de/10011377471
Persistent link: https://www.econbiz.de/10011457870
Persistent link: https://www.econbiz.de/10010391778
We estimate the effect of information on consumers' willingness to pay for branded goods in physically homogeneous consumer packaged goods categories. In a case study of headache remedies, we find that college education, working in a healthcare occupation, and other proxies for product knowledge...
Persistent link: https://www.econbiz.de/10013006238